What is the appropriate augmentin (amoxicillin‑clavulanate) dose for an 87‑year‑old patient with chronic kidney disease stage IV being treated for bacterial sinusitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 14, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Dose Adjustment for Augmentin in CKD Stage IV

For an 87-year-old patient with CKD Stage IV (GFR 15-29 mL/min) being treated for bacterial sinusitis, use Augmentin 500/125 mg orally every 12 hours for 5-7 days. This represents a 50% dose reduction from the standard adult dose due to severely impaired renal clearance of both amoxicillin and clavulanate.

Rationale for Dose Selection

The standard adult dose for acute bacterial sinusitis is amoxicillin-clavulanate 875/125 mg twice daily 1. However, both amoxicillin and clavulanate are primarily renally excreted, requiring significant dose adjustment in CKD Stage IV 2.

In patients with severe renal impairment (CrCl <30 mL/min), the elimination half-life of amoxicillin increases from 1-1.5 hours to 7-20 hours, creating substantial risk for drug accumulation and toxicity if standard doses are used 3, 4. The clavulanate component similarly accumulates, though to a lesser degree.

Specific Dosing Algorithm

For CKD Stage IV (GFR 15-29 mL/min):

  • Dose: 500/125 mg orally every 12 hours
  • Duration: 5-7 days (adult standard) 1, 5
  • Timing: Can be given without regard to meals, though taking with food may reduce GI side effects

If patient were on hemodialysis (ESRD):

  • Give 500/125 mg after each dialysis session (typically 3 times weekly)
  • Add supplemental 250/125 mg dose if dialysis session >4 hours 2

Important Clinical Considerations

Why Not Higher Doses?

While high-dose amoxicillin-clavulanate (2000/125 mg twice daily) is recommended for patients at high risk of resistant organisms 1, 5, this elderly patient with CKD Stage IV cannot safely receive high-dose therapy. The risk of drug accumulation and toxicity (including seizures, crystalluria, and hepatotoxicity) outweighs potential benefits 2.

Monitoring Requirements

  • Watch for adverse effects: Diarrhea, nausea, and yeast infections are more common with amoxicillin-clavulanate than amoxicillin alone 6, 7
  • Assess clinical response at 48-72 hours: If no improvement, consider alternative diagnosis or resistant pathogen 1, 5
  • Monitor renal function: Further decline in kidney function may necessitate additional dose adjustment

Alternative Considerations

If the patient has risk factors for resistant organisms (recent antibiotic use, healthcare exposure, severe infection), consider a respiratory fluoroquinolone (levofloxacin or moxifloxacin) instead, as these also require renal dose adjustment but may provide better coverage 1. However, for uncomplicated sinusitis in this age group, the dose-adjusted amoxicillin-clavulanate remains appropriate first-line therapy.

Critical Pitfall to Avoid

Do not use standard adult dosing (875/125 mg twice daily) in this patient. The severely reduced renal clearance will lead to drug accumulation over 5-7 days of therapy, substantially increasing risk of adverse effects including CNS toxicity (confusion, seizures), particularly concerning in an elderly patient 2, 4.

Duration of Therapy

The 5-7 day course is appropriate for uncomplicated acute bacterial sinusitis in adults 1, 5. Do not extend therapy beyond 7 days unless there is documented treatment failure, as prolonged courses increase risk of adverse effects and secondary infections (particularly Clostridioides difficile) without improving outcomes 6.

Related Questions

Should a 5-year-old child with acute bacterial sinusitis be treated with Augmentin (amoxicillin‑clavulanate), and what is the appropriate dose and duration?
When should Augmentin (amoxicillin‑clavulanate) be chosen over amoxicillin for treating infections?
In a patient who has not yet taken the prescribed amoxicillin‑clavulanate after yesterday’s hemodialysis and will have another dialysis session tomorrow, how should the dosing be scheduled?
A 35-year-old woman with sinus congestion and sore throat who completed a 7‑day course of Augmentin (amoxicillin‑clavulanate) reports worsening symptoms; what are the next steps in management?
What is the appropriate Augmentin (amoxicillin/clavulanate) dose for a 33 kg child with acute sinusitis?
How do my cervical spine MRI T2‑hyperintense lesions (C3‑C5) and cerebellar white‑matter hyperintensity relate to my anti‑RNP‑positive mixed connective‑tissue disease with elevated creatine‑kinase, mild CRP elevation, proximal muscle weakness with wasting, and restless‑leg‑type symptoms?
In a 62-year-old female with an A1c of 6.5% managed with diet, aspartate aminotransferase (AST) 77 U/L, alanine aminotransferase (ALT) 38 U/L, and hyperlipidemia controlled with rosuvastatin (generic) 10 mg daily, should I start pharmacologic therapy for diabetes?
Explain disseminated intravascular coagulation (DIC).
Is Mucinex DM (guaifenesin and dextromethorphan) safe for use?
Is it safe to start metformin in a patient with an estimated glomerular filtration rate (eGFR) of 74 mL/min/1.73 m²?
How should nausea and vomiting associated with aripiprazole be managed?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.